Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness.
Rybinska I, Mangano N, Romero-Cordoba SL, Regondi V, Ciravolo V, De Cecco L, Maffioli E, Paolini B, Bianchi F, Sfondrini L, Tedeschi G, Agresti R, Tagliabue E, Triulzi T. Rybinska I, et al. Among authors: agresti r. Int J Cancer. 2024 May 15;154(10):1842-1856. doi: 10.1002/ijc.34859. Epub 2024 Jan 30. Int J Cancer. 2024. PMID: 38289016 Free article.
Adipocytes in Breast Cancer, the Thick and the Thin.
Rybinska I, Agresti R, Trapani A, Tagliabue E, Triulzi T. Rybinska I, et al. Among authors: agresti r. Cells. 2020 Feb 27;9(3):560. doi: 10.3390/cells9030560. Cells. 2020. PMID: 32120856 Free PMC article. Review.
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M. Turdo F, et al. Among authors: agresti r. Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935. Oncotarget. 2016. PMID: 27626701 Free PMC article.
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
Forte L, Turdo F, Ghirelli C, Aiello P, Casalini P, Iorio MV, D'Ippolito E, Gasparini P, Agresti R, Belmonte B, Sozzi G, Sfondrini L, Tagliabue E, Campiglio M, Bianchi F. Forte L, et al. Among authors: agresti r. BMC Cancer. 2018 May 23;18(1):586. doi: 10.1186/s12885-018-4500-9. BMC Cancer. 2018. PMID: 29792166 Free PMC article.
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.
Plantamura I, Casalini P, Dugnani E, Sasso M, D'Ippolito E, Tortoreto M, Cacciatore M, Guarnotta C, Ghirelli C, Barajon I, Bianchi F, Triulzi T, Agresti R, Balsari A, Campiglio M, Tripodo C, Iorio MV, Tagliabue E. Plantamura I, et al. Among authors: agresti r. Mol Oncol. 2014 Jul;8(5):968-81. doi: 10.1016/j.molonc.2014.03.015. Epub 2014 Mar 27. Mol Oncol. 2014. PMID: 24747080 Free PMC article.
Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Agresti R, Martelli G, Sandri M, Tagliabue E, Carcangiu ML, Maugeri I, Pellitteri C, Ferraris C, Capri G, Moliterni A, Bianchi G, Mariani G, Trecate G, Lozza L, Langer M, Rampa M, Gennaro M, Greco M, Menard S, Pierotti MA. Agresti R, et al. Cancer. 2014 Mar 15;120(6):885-93. doi: 10.1002/cncr.28499. Epub 2013 Dec 5. Cancer. 2014. PMID: 24323615 Free article. Clinical Trial.
89 results